Lemaitre Vascular [LMAT] vs Baxter International [BAX] Detailed Stock Comparison

Lemaitre Vascular Inc.

NASDAQ
Loading...

Baxter International Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Lemaitre Vascular Inc. wins in 11 metrics, Baxter International Inc. wins in 10 metrics, with 0 ties. Lemaitre Vascular Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Lemaitre Vascular Inc. Baxter International Inc. Better
P/E Ratio (TTM) 44.80 86.31 Lemaitre Vascular Inc.
Price-to-Book Ratio 6.53 1.54 Baxter International Inc.
Debt-to-Equity Ratio 47.16 160.28 Lemaitre Vascular Inc.
PEG Ratio 1.18 0.73 Baxter International Inc.
EV/EBITDA 32.62 8.55 Baxter International Inc.
Profit Margin (TTM) 23.13% -8.51% Lemaitre Vascular Inc.
Operating Margin (TTM) 21.77% 7.36% Lemaitre Vascular Inc.
EBITDA Margin (TTM) 21.77% 7.36% Lemaitre Vascular Inc.
Return on Equity 15.80% -13.71% Lemaitre Vascular Inc.
Return on Assets (TTM) 6.76% 2.83% Lemaitre Vascular Inc.
Free Cash Flow (TTM) $74.47M $323.00M Baxter International Inc.
Dividend Yield 0.97% 1.77% Baxter International Inc.
1-Year Return 15.15% -38.43% Lemaitre Vascular Inc.
Price-to-Sales Ratio (TTM) 10.33 0.85 Baxter International Inc.
Enterprise Value $2.40B $17.26B Baxter International Inc.
EV/Revenue Ratio 9.61 1.54 Baxter International Inc.
Gross Profit Margin (TTM) 71.66% 19.40% Lemaitre Vascular Inc.
Revenue per Share (TTM) $11 $22 Baxter International Inc.
Earnings per Share (Diluted) $2.52 $-1.75 Lemaitre Vascular Inc.
Beta (Stock Volatility) 0.67 0.62 Baxter International Inc.
Short % of Float 7.34% 12.33% Lemaitre Vascular Inc.

Lemaitre Vascular Inc. vs Baxter International Inc. Stock Performance Analysis

Loading Price Chart...

LMAT
BAX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Lemaitre Vascular Inc.0.02%-4.26%-17.83%-15.03%7.91%14.31%
Baxter International Inc.-0.75%-4.09%11.55%-2.57%-1.85%-4.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Lemaitre Vascular Inc.15.15%45.82%84.43%536.52%1,252.14%1,367.44%
Baxter International Inc.-38.43%-54.56%-77.17%-56.81%-40.32%-9.28%

Performance & Financial Health Analysis: Lemaitre Vascular Inc. vs Baxter International Inc.

MetricLMATBAX
Market Information
Market Cap i$2.59B$9.38B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i168,1056,387,585
90 Day Avg. Volume i227,8687,931,785
Last Close$91.64$18.54
52 Week Range$79.01 - $118.01$15.73 - $32.04
% from 52W High-22.35%-42.13%
All-Time High$118.12 (Apr 14, 2026)$95.19 (Apr 20, 2020)
% from All-Time High-22.42%-80.52%
Growth Metrics
Quarterly Revenue Growth0.16%0.08%
Quarterly Earnings Growth0.39%0.08%
Financial Health
Profit Margin (TTM) i0.23%-0.09%
Operating Margin (TTM) i0.22%0.07%
Return on Equity (TTM) i0.16%-0.14%
Debt to Equity (MRQ) i47.16160.28
Cash & Liquidity
Book Value per Share (MRQ)$17.28$11.92
Cash per Share (MRQ)$15.77$3.82
Operating Cash Flow (TTM) i$81.25M$845.00M
Levered Free Cash Flow (TTM) i$47.35M$2.43B
Dividends
Last 12-Month Dividend Yield i0.97%1.77%
Last 12-Month Dividend i$1.05$0.36

Valuation & Enterprise Metrics Analysis: Lemaitre Vascular Inc. vs Baxter International Inc.

MetricLMAT (Apr 26, 2026)BAX (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i44.8086.31
Forward P/E i35.459.09
PEG Ratio i1.180.73
Price to Sales (TTM) i10.330.85
Price to Book (MRQ) i6.531.54
Market Capitalization
Market Capitalization i$2.59B$9.38B
Enterprise Value i$2.40B$17.26B
Enterprise Value Metrics
Enterprise to Revenue i9.611.54
Enterprise to EBITDA i32.628.55
Risk & Other Metrics
Beta i0.670.62
Book Value per Share (MRQ) i$17.28$11.92

Financial Statements Comparison: Lemaitre Vascular Inc. vs Baxter International Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLMAT (2025)BAX (2025)
Revenue/Sales i249.60M11.24B
Cost of Goods Sold i71.06M7.87B
COGS % of Revenue i28.5%69.9%
Gross Profit i178.54M3.38B
Gross Margin i71.5%30.1%
Research & Development i14.14M518.00M
Operating Income (EBIT) i67.91M177.00M
Operating Margin i27.2%1.6%
EBITDA i77.69M1.26B
EBITDA Margin i31.1%11.2%
Pre-Tax Income i75.18M-505.00M
Pre-Tax Income % of Revenue i30.1%-4.5%
Income Tax i17.45M395.00M
Income Tax % of Revenue i7.0%3.5%
Net Income (Profit) i57.73M-957.00M
Profit Margin i23.1%-8.5%

Balance Sheet & Liquidity Metrics

MetricLMAT (2025)BAX (2025)
Cash & Equivalents i28.24M1.97B
Total Current Assets i468.23M6.87B
Total Current Assets % of Revenue i187.6%61.1%
Total Current Liabilities i36.32M2.97B
Total Current Liabilities % of Revenue i14.6%26.4%
Long-Term Debt i182.65M9.70B
Long-Term Debt % of Revenue i73.2%86.2%
Total Shareholders Equity i393.52M6.10B
Retained Earnings i184.72M13.71B
Retained Earnings % of Revenue i74.0%121.9%
Property, Plant & Equipment i41.92M651.00M

Cash Flow Statement Comparison

MetricLMAT (2025)BAX (2025)
Operating Cash Flow i73.19M-24.00M
Operating Cash Flow % of Revenue i29.3%-0.2%
Capital Expenditures i-6.78MN/A
Free Cash Flow i74.47M323.00M
FCF Margin i29.8%2.9%
Debt Repayment iN/A-5.79B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricLMATBAX
Shares Short i1.33M40.31M
Short Ratio i4.884.11
Short % of Float i7.34%12.33%
Shares Outstanding i22.77M514.28M
Float Shares i21.15M512.05M
% Held by Insiders i6.89%0.32%
% Held by Institutions i97.09%109.89%
% Held by Public i-3.98%-10.21%

Dividend Analysis & Yield Comparison: Lemaitre Vascular Inc. vs Baxter International Inc.

MetricLMATBAX
Last 12-Month Dividend i$1.05$0.36
Last 12-Month Dividend Yield i0.97%1.77%
3-Year Avg Annual Dividend i$0.75$0.81
3-Year Avg Dividend Yield i0.23%0.57%
3-Year Total Dividends i$2.25$2.44
Ex-Dividend DateMar 12, 2026Feb 27, 2026